This proposal is for continuation of long-standing research studies in our laboratory that focused on HIV-1 cell-specific tropism. This proposal addresses three related topics based on their innovative and unique approaches and promising recent preliminary findings that will provide a comprehensive view of HIV entry.
The aims have been focused based on study section critiques and exciting new findings.
Aim 1. Cell Biology Studies of Fusion- Role of the Actin Filament Network. We found that inhibitors of actin-based dynamics, as well as dominant-negative mutants of Rhofamily GTPase, Rac, blocked HIV-mediated cell-cell fusion. The current studies ask, a) Is Rac activation required for virus-cell fusion? b) Does SU ligation with CD4 and coreceptor activate Rac? c) Which signaling pathway, activated by Rac, is critical for HIV-1 fusion? Aim 2. Role of Tetraspan Proteins in HIV Entry We will extend preliminary findings suggesting a role of the tetraspan protein, CD9, in HIV entry, to examine its mechanism of action. The current studies ask, a) Is CD9 important in the producer or target cells? b) Does CD9 promote virus uncoating and/or targeting the viral core to the site of PIC formation? c) Do CD9 and CD63 function in the same way in promoting infection? d) What domains of CD9 are critical for this activity? Aim 3. Coreceptor-Envelope Interactions We will extend our previous studies of X4 and SU determinants to map the interactive domains of each. a) We will focus on the minimal domains of X4 extracellular loops (ECL) 2 and 3 that mediate SU binding, fusion, and virus entry, b) We will also examine the evolution of HIV-1 isolates to use X4 using the R5/X4 chimeras.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI024745-15A2
Application #
6841919
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Wassef, Nabila M
Project Start
1987-04-01
Project End
2008-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
15
Fiscal Year
2004
Total Cost
$267,750
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Hood, Joshua L; Jallouk, Andrew P; Campbell, Nancy et al. (2013) Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther 18:95-103
McCulley, Anna; Ratner, Lee (2012) HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection. Virology 427:67-75
Belshan, Michael; Kimata, Jason T; Brown, Charles et al. (2012) Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology 9:32
Harmon, Brooke; Campbell, Nancy; Ratner, Lee (2010) Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog 6:e1000956
Zhang, Menghua; Evans, Stella; Yuan, Jinyun et al. (2010) HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region. Virology 401:131-6
Bhatia, Ajay K; Kaushik, Rajnish; Campbell, Nancy A et al. (2009) Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail. Virology 384:233-41
Harmon, Brooke; Ratner, Lee (2008) Induction of the Galpha(q) signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J Virol 82:9191-205
Cheng, Xiaogang; Belshan, Michael; Ratner, Lee (2008) Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex. J Virol 82:1229-37
Salim, Aneeza; Ratner, Lee (2008) Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release. J Virol 82:3932-8
Bhatia, Ajay K; Campbell, Nancy; Panganiban, Antonito et al. (2007) Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix. Virology 369:47-54

Showing the most recent 10 out of 46 publications